PD Dr. Luis Munoz Becerra

Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease: Btn2a2 promotes central tolerance (2023) Frech M, Danzer H, Uchil P, Azizov V, Schmid E, Schälter F, Dürholz K, et al. Journal article IL-3 orchestrates ulcerative colitis pathogenesis by controlling the development and the recruitment of splenic reservoir neutrophils (2023) Benard A, Mittelstädt A, Klösch B, Glanz K, Müller J, Schoen J, Nüse B, et al. Journal article Anti-DNA-IgM Favors the Detection of NET-Associated Extracellular DNA (2023) Wang H, Stehr A, Singh J, Zlatar L, Hartmann A, Evert K, Naschberger E, et al. Journal article Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. (2023) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article, Erratum A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19 (2022) Singh J, Herrmann I, Mahajan A, Schauer C, Shan X, Hartmann A, Rieker R, et al. Journal article Early Histopathological Changes of the Salivary Glands Associated with the Development of Primary Sjogren's Syndrome (2022) Shan X, Reichardt C, Singh J, Zeitler A, Schauer C, Knopf J, Herrmann M, et al. Conference contribution Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects (2022) Sun R, Xu Z, Zhu C, Chen T, Munoz LE, Dai L, Zhao Y Journal article Induction of Ocular Surface Inflammation and Collection of Involved Tissues (2022) Singh J, Shan X, Mahajan A, Herrmann M, Schauer C, Knopf J, Munoz Becerra L Journal article Hypoxia Promotes Neutrophil Survival After Acute Myocardial Infarction (2022) Dölling M, Eckstein M, Singh J, Schoen J, Shan X, Bozec A, Knopf J, et al. Journal article Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial(Front. Immunol., (2021), 12, (740742), 10.3389/fimmu.2021.740742) (2022) Donaubauer AJ, Becker I, Weissmann T, Fröhlich B, Munoz LE, Gryc T, Denzler M, et al. Journal article, Erratum